Pediatric apheresis with a novel apheresis device with electronic interface control

BACKGROUND: Cancer in children, and specifically cancer requiring autologous stem cell transplantation, is rare. As a consequence, though, experience with pediatric stem cell apheresis collections is limited. Challenges of apheresis in small children (<20 kg) include small total blood volume, issues with venous access, concerns about tolerable anticoagulant doses, and limitations in product volumes that can safely be collected.

[1]  B. Yalçın,et al.  High-dose chemotherapy and autologous haematopoietic stem cell rescue for children with high-risk neuroblastoma. , 2015, The Cochrane database of systematic reviews.

[2]  E. Seifried,et al.  Allogeneic donor peripheral blood “stem cell” apheresis: prospective comparison of two apheresis systems , 2012, Transfusion.

[3]  H. Sauer,et al.  Leukapheresis in children weighing less than 20 kg , 2012, Pediatric blood & cancer.

[4]  E. Seifried,et al.  Mobilized allogeneic peripheral stem/progenitor cell apheresis with Spectra Optia v.5·0, a novel, automatic interface‐controlled apheresis system: results from the first feasibility trial , 2011, Vox sanguinis.

[5]  E. Seifried,et al.  Automatic interface‐controlled apheresis collection of stem/progenitor cells: results from an autologous donor validation trial of a novel stem cell apheresis device , 2011, Transfusion.

[6]  E. Seifried,et al.  Enumeration of viable CD34(+) cells by flow cytometry in blood, bone marrow and cord blood: results of a study of the novel BD™ stem cell enumeration kit. , 2011, Cytotherapy.

[7]  J. Winters,et al.  Comparison of hematopoietic progenitor cell collections using the COBE Spectra version 7 and Amicus version 3.1 for patients with al amyloidosis , 2011, Journal of clinical apheresis.

[8]  J. Finlay,et al.  Is there a role for myeloablative chemotherapy with autologous hematopoietic cell rescue in the management of childhood high‐grade astrocytomas? , 2010, Pediatric blood & cancer.

[9]  J. Fish,et al.  Autologous and allogeneic cellular therapies for high-risk pediatric solid tumors. , 2010, Pediatric clinics of North America.

[10]  R. Skeate,et al.  Distinguishing between transfusion related acute lung injury and transfusion associated circulatory overload , 2007, Current opinion in hematology.

[11]  R. Ritter,et al.  Performance of a new separator system for routine autologous hematopoietic progenitor cell collection in small children , 2007, Journal of clinical apheresis.

[12]  E. T. Ek,et al.  The role of high-dose therapy and autologous stem cell transplantation for pediatric bone and soft tissue sarcomas , 2006, Expert review of anticancer therapy.

[13]  K. Ikeda,et al.  Collection of MNCs and progenitor cells by two separators for PBPC transplantation: a randomized crossover trial , 2003, Transfusion.

[14]  D. Printz,et al.  Collection efficiencies of MNC subpopulations during autologous CD34+ peripheral blood progenitor cell (PBPC) harvests in small children and adolescents , 2001, Journal of clinical apheresis.